The 50th annual meeting of the American Society of Hematology will take place in San Francisco, CA from December 6 – 9, 2008. Many hematologic cancers are now covered at the annual American Society of Clinical Oncology (ASCO) meeting, so a number of the presentations at ASH will be an update of data seen at the 2008 ASCO meeting. This report highlights indications with oral presentations that will be presented at ASH this year. The post-ASH report will provide further details on these presentations and a synopsis of the events added to BioMedTracker from the meeting.

Please note that the abstracts summarizing the trial data presented at ASH are available for review on the ASH website. We are prohibited from analyzing the data until the actual presentations are made at ASH.

For the full report, please download the PDF version at the top of this page.

For our disclosures, please read the BioMedTracker Research Standards.